It is clear that this is pathophysiologically a valid model of ALS (since SOD1 mutations cause the disease in humans), and it is known that the model has predictive validity (since Riluzole, the only drug approved for human ALS patients produces an increase in survival in SOD1G93A mice [5]). Here, SOD1 is linked to amyotrophic lateral sclerosis.